Research conducted on transgenic mice with human wild‐type α‐Syn revealed that overexpression of C/EBPβ led to increased levels of α‐Syn, resulting in augmented PD pathologies and motor disorders. The gene discussed is CEBPB; the disease is Parkinson disease.